(Q38688190)

5 September 2017

1 reference

title

Pathogenesis and treatment of steroid osteoporosis (English)

1 reference

5 September 2017

0 references

0 references

Reid IR

1

1 reference

5 September 2017

publication date

1 January 1989

1 reference

5 September 2017

published in

Clinical Endocrinology

1 reference

5 September 2017

volume

30

1 reference

5 September 2017

issue

1

1 reference

5 September 2017

page(s)

83-103

1 reference

Treatment of osteoporosis with calcitonin, with and without growth hormone

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

The Effect of Prednisolone® upon the Metabolism and Action of 25-Hydroxy and 1,25-Dihydroxyvitamin D 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells. Mechanism of dexamethasone potentiation of parathyroid hormone-stimulated cyclic AMP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Metabolic effects of corticosteroid therapy in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Different schedules of administration of (3 amino-1-hydroxypropylidene)-1, 1 bisphosphonate induce different changes in pig bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Cortisol enhancement of PTH-stimulated cyclic AMP accumulation in cultured fetal rat long bone rudiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Bone mass as referent for urinary hydroxyproline excretion: age and sex-related changes in 125 normals and in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

The in vitro effect of indomethacin on basal bone resorption, on prostaglandin production and on the response to added prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

PLASMA KETOSTEROIDS AND TESTOSTERONE IN MAN: A STUDY OF THE PITUITARY-TESTICULAR AXIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Oral 1,25(OH)2D3: an effective prophylactic treatment for glucocorticoid osteopenia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Reduction of serum testosterone levels during chronic glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Plasma growth hormone concentration in corticosteroid-treated children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Proceedings: Bone mineral determinations on long-term diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Mineral loss in cortical and trabecular bone during high-dose prednisone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Growth Hormone: Metabolic Clearance Rates, Integrated Concentrations, and Production Rates in Normal Adults and the Effect of Prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Effect of cortisone therapy on the diurnal pattern of growth hormone secretion in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Glucocorticoids increase osteoblast-like bone cell response to 1,25(OH)2D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1989.TB03730.X

10.1111/J.1365-2265.1989.TB03730.X

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference